Craig Waldman, who co-chairs Jones Day's global Antitrust Practice, has more than 20 years of experience representing companies in antitrust government investigations, private litigations, and by counseling them on how to manage antitrust risk in daily business activities. Craig's work has included all areas of antitrust including mergers, agreements among competitors, vertical distribution issues, price discrimination, criminal antitrust matters, monopolization, and intellectual property licensing and trade regulation.
He has worked across many industries, including IT hardware and software, networking, electronic design automation, electronic platforms, health care, consumer products, credit cards, financial institutions, medical devices, defense, sports, financial markets, life sciences, oil and gas, retail stores, satellites, telecommunications, tobacco, and transportation. The companies Craig represents include Dignity Health, Lam Research, NVIDIA, Reynolds, SAP, Synopsys, and Wabtec.
From 1993 to 1996, Craig served as an attorney in the Federal Trade Commission's Mergers I division during which time he was involved in high-profile investigations including Rite Aid's attempted acquisition of Revco, Lockheed's purchase of Martin Marietta, First Financial's merger with First Data, and Glaxo's acquisition of Wellcome, among others.
Craig is a frequent speaker on all antitrust issues. He has served as an adjunct professor at both Berkeley and Hastings Law Schools, has lectured at Stanford Business School, and has served in numerous roles within ABA Antitrust Leadership.
For over 10 years, he has served on the board of directors of Global Strategies, an international charity whose mission is to reduce early mortality and treat survivors of sexual violence in impoverished and war torn regions of Africa.
- November/December 2016DOJ & FTC Human Resources Guidance Reminds Practitioners About Antitrust Risk in the M&A Context, The M&A Lawyer, Volume 20, Issue 10
- April 2013Getting The Tough Deal Done: The Roles of The General Counsel and Outside Antitrust Counsel, CPI Antitrust Chronicle
- July/August 2011Mergers of Competitors: Negotiating Remedies to Resolve U.S. Antitrust Concerns, The M&A Lawyer
- May 2011Antitrust Enforcement Against Vertical Mergers on the Rise: Implications for Dealmaking, The M&A Lawyer
- April 2010Antitrust Issues in Clean Technology, Antitrust Source
- February 2016Mergers: Who, What, Where, When, Why and How: A practical view on guiding a transaction through the remedy process, panel moderator, Annual Antitrust Law Leaders Forum co-sponsored by GCR, Charles River Associates, and the University of Florida
- January 2015Roundtable discussions on the current key issues raised by the intersection between antitrust and M&A, Antitrust, Governance, M&A in 2015 sponsored by Berkeley Center for Law, Business and the Economy
- October 11, 2013Hot Topics in Competition Law, State Bar of California Annual Meeting
- October 10, 2013Patent Pools Face New Antitrust Threats, Stanford ABA Antitrust/IP conference
- March 14, 2012Apple, Google, IBM and Other IT Giants Under the Antitrust Nanoscope, panelist, GCR Antitrust & Technology 2012 conference
- January 26, 2011Antitrust and IP Licensing, Jones Day MCLE University (Presentation slides)
- September 15, 2009Annual seminar on Antitrust for the Westchester/Southern Connecticut chapter of the Association of Corporate Counsel (WESFACCA)
- The University of Michigan (J.D. 1993); Cornell University (B.S. in Policy Analysis, concentration in Antitrust Policy, 1990)
- Staff attorney, Mergers I, Federal Trade Commission (1993-1996)
Daily Journal — Top 100 Lawyers in California (2017)
Best Lawyers in America (2015-2018)
Northern California Super Lawyers (2013)
The Legal 500 US (2012-2016)
San Francisco Chronicle "Top Attorney" (2011)
Chambers USA (2009-2017) — "praised for his understanding of technology markets"
GC California (2008) — recognized as The Preferred Antitrust/Unfair Competition Counsel in California